An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
about
Evidence and evidence gaps of medical treatment of non-tumorous diseases of the head and neckMite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?Indoor Allergens and Allergic Respiratory DiseaseInternational consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem.Changes in skin reactivity and associated factors in patients sensitized to house dust mites after 1 year of allergen-specific immunotherapy.Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response PredictorsImmunotherapy for house dust mite sensitivity: where are the knowledge gaps?Three-Year Follow-up Results of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitized to House Dust Mites"The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoEfficacy of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials.Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma: an umbrella reviewA 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patientsHouse dust mite sublingual tablet is effective and safe in patients with allergic rhinitisProgress in the development of specific immunotherapies for house dust mite allergies.Current developments for improving efficacy of allergy vaccines.Variation in allergen content in sublingual allergen immunotherapy with house dust mitesEfficacy and safety of sublingual immunotherapy in children.Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents.New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs).Investigational new drugs for allergic rhinitis.Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world.Outcome of sublingual immunotherapy in patients with allergic rhinitis sensitive to house dust mites.Initial immunological changes as predictors for house dust mite immunotherapy response.Immunotherapy of house dust mite allergy.Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.The relevance of house dust mites allergy in clinical practice: the epidemiological impact on allergen immunotherapy.Efficacy of sublingual immunotherapy for house dust mite allergic rhinitis.Side effects during subcutaneous immunotherapy in children with allergic diseases.A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients.Randomized dose-response study of subcutaneous immunotherapy with a Dermatophagoides pteronyssinus extract in patients with respiratory allergy.Specific immunotherapy for rhinitis and asthma with a subcutaneous hypoallergenic high-dose house dust mite extract: results of a 9-month therapy.The Relevance of Nasal Cytology in the Workup of House Dust Mite-Induced Allergic Rhinitis.Cross-sectional study on sensitization to mite and cockroach allergen components in allergy patients in the Central European region.
P2860
Q28070005-357E40FC-E1CD-4B95-9B3D-44790B5B18FDQ28082353-9B7D3527-146A-4ED4-B9E3-E245D0D306DFQ28386020-5D28646B-C76A-4490-8FF5-ABB533D8C5F6Q33572979-636C3789-5B57-4CAE-B38A-1455EFC8CA88Q33619064-88B85510-42A3-45C3-A353-2BF4D153FAB8Q33770349-2D54DB05-DFA9-40B3-9BF9-82253FD6A79EQ34445398-DAB4626D-98BE-4848-A639-52B33D8836B5Q35123899-8FC3B3A6-BEB0-4B7E-BFBE-7DBE573E1AA6Q35564301-A76763DA-3231-4905-9530-C78A6E3D0C18Q35777126-918D1303-2354-4B24-93D8-ABF63D307AD9Q36308157-8898A6A8-89C1-451B-A060-FB1314129DD4Q36369716-45DF655C-4543-4A95-B187-A52B34347DF3Q37565596-1635B705-0956-46DE-8872-A3808E39DC2AQ37663911-58BFCA0B-5D03-45DB-A09B-88D2B06AEC1BQ38245974-BF0FF0E8-28E4-4CD3-B42A-4B717CD52D36Q38503330-4D5A2305-A8B1-4703-B2C6-C8A0115D02DDQ38549315-43454E37-7B99-4DB7-9053-8B7B74BAB735Q38615030-53E336E9-1244-4A81-A197-652FDFEF2D43Q38703027-1993605C-A3DF-44DD-9BF1-9B20EFA31AA1Q38837264-2788F64A-68F0-4E58-957F-6C585703BCD4Q39111947-56B4DAFF-42CE-492A-91FA-AFB4D45B80B7Q41861659-D680D800-2879-48EA-9512-1994BC3E034EQ42024889-57154EFF-1EF5-448D-A497-DCFDB4AA4ABFQ42477747-01141358-FE3B-4CD2-A3A8-7A135C9B4590Q43915564-48BFBBF0-1DE5-4D17-958C-72722CB97545Q46651312-EB546E13-31A8-433D-8A13-AAE9F7C8F3D0Q47713962-049CAEAF-5DEC-46B1-8323-276F6AFF4F0EQ48056038-44ECA3E1-A864-46BE-A72F-97E941EFAC8EQ48106002-58139DE6-531D-43F3-8BAD-D8E5D8110A90Q49073680-C716233D-B439-4C62-A872-25E516A73F2EQ51557000-060271E2-AC8A-47CC-A398-E1B3C9427566Q53608022-C56F085D-E8A9-4C60-9807-108E6809C3F5Q55114453-1CA7E65A-31C9-4A89-BFC4-8185C052349DQ55285249-80129993-FE31-466A-8A29-79C74DA4AECD
P2860
An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An evidence-based analysis of ...... ore rigorous clinical studies.
@en
type
label
An evidence-based analysis of ...... ore rigorous clinical studies.
@en
prefLabel
An evidence-based analysis of ...... ore rigorous clinical studies.
@en
P2093
P1476
An evidence-based analysis of ...... more rigorous clinical studies
@en
P2093
Harold S Nelson
Moises A Calderon
Thomas B Casale
P304
P356
10.1016/J.JACI.2013.09.004
P407
P50
P577
2013-10-18T00:00:00Z